Advertisement
Advertisement
BNTC
Benitec Biopharma Inc. Common Stock
11.51
USDSponsored
+0.04
+0.35%
Jul 27, 13:08 UTC -4
Open
BNTC Earnings Reports
Positive Surprise Ratio
BNTC beat 9 of 21 last estimates.
43%
Next Report
Date of Next Report
Sep 21, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.28
Implied change from Q3 26 (Revenue/ EPS)
--
/+16.67%
Implied change from Q4 25 (Revenue/ EPS)
--
/-33.33%
Benitec Biopharma Inc. Common Stock earnings per share and revenue
On May 14, 2026, BNTC reported earnings of -0.24 USD per share (EPS) for Q3 26, beating the estimate of -0.27 USD, resulting in a 14.01% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.72% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 8 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an increase of 16.67% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Benitec Biopharma Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Benitec Biopharma Inc. Common Stock reported EPS of -$0.24, beating estimates by 14.01%, and revenue of $0.00, 0% as expectations.
How did the market react to Benitec Biopharma Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 1.72%, changed from $11.65 before the earnings release to $11.85 the day after.
When is Benitec Biopharma Inc. Common Stock expected to report next?
The next earning report is scheduled for Sep 21, 2026.
What are the forecasts for Benitec Biopharma Inc. Common Stock's next earnings report?
Based on 8
analysts, Benitec Biopharma Inc. Common Stock is expected to report EPS of -$0.28 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement